 |
 |
|
|
Resources for Food and Drug Administration (FDA)Resources > FDA > ArticlesSub-Categories: Listings 201 - 210 of 1028:
FDA Agent Faults Sanofi-Aventis for Ketek Trial Troubles
Just when you think it’s all Vytorin all the time in Congress, they change things up a bit. Michigan Democrats John Dingell and Bart Stupak took a Vyt...
FDA Alert Outlines Risk of Conventional Antipsychotic Use in Older Patients
In an alert issued June 16, the FDA notified physicians that the agency has directed manufacturers of conventional antipsychotic drugs to add specific...
FDA alerts of Risks with Transplant Drugs in Pregnant Women
The Food and Drug Administration warned one more time about the risks of Novartis and Roche transplant drugs for pregnant woman.On Friday, the U.S. he...
FDA Allowing Heartworm Drug For Dogs Back In US
The U.S. Food and Drug Administration on Thursday said it will allow a reformulated version of a Wyeth (WYE) heartworm drug for dogs back into the U.S...
FDA allows functionality claim for live yeast
The Center for Veterinary Medicine of the FDA has agreed to allow an important functionality claim for live yeast applied in ruminant feeding. The ...
FDA and AAFCO agree on ingredients list
The US Food and Drug Administration (FDA) Center for Veterinary Medicine has signed a memorandum of understanding with the Association of American Fee...
FDA and Drug Marketing
The Food and Drug Administration is developing a proposal for how drug companies can inform doctors about drug uses that aren't FDA approved, a conten...
FDA and Duke Launch Public-Private Partnership to Modernize Clinical Trials
The U.S. Food and Drug Administration and Duke University Medical Center have begun a collaboration aimed at modernizing the way clinical trials are c...
FDA and FTC Tell Monsanto to Quit Bellyaching
Earlier this year Monsanto petitioned the two federal agencies to bitch-slap milk producers who have made "deceptive" claims that say or imply dastard...
FDA and Health Insurers Take On Drugmakers
The U.S. has fairly rigorous standards for approving drugs, but its ability to find side effects after drugs are on the market is kind of laughable. E... |
|
RSS Feeds|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2008 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |
 |
 |